Evidence map›Paper›PMID 23550723›Full record

ArticleJournal of proteome research2013

Proteomic analysis of human bronchoalveolar lavage fluid after subsgemental exposure.

Matthew W Foster, J Will Thompson, Loretta G Que, Ivana V Yang, David A Schwartz, M Arthur Moseley, Harvey E Marshall

Open access · greenAbstract read
In one paragraph

Article in Journal of proteome research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. HBFP: a new repository for human body fluid proteome.Database : the journal of biological databases and curation · 2021
    Article
  5. Article
  6. Review
  7. Application of Proteomics in Sarcoidosis.American journal of respiratory cell and molecular biology · 2020
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Matthew W FosterDivision of Pulmonary, Allergy and Critical Care Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA. mwfoster@duke.edu
J Will Thompson
Loretta G Que
Ivana V Yang
David A Schwartz
M Arthur Moseley
Harvey E Marshall
University of Colorado Denver · USDuke Medical Center · US

Funding

Pilot Project for the DTMI CRA ProgramUL1RR024128 · NCRR · DUKE UNIVERSITY · PI CALIFF, ROBERT M · 2006 to 2010
$48.1M
The Pathogenesis and Genetics of Environmental AsthmaU19ES012496 · NIEHS · DUKE UNIVERSITY · PI FOSTER, WILLIAM MICHAEL · 2004 to 2007
$6.4M
Modulation of Asthma by GSNO-based TherapiesR01HL107590 · NHLBI · DUKE UNIVERSITY · PI FOSTER, MATTHEW WOLF, QUE, LORETTA G · 2013 to 2016
$1.6M
The Pathogenesis and Genetics of Environmental AsthmaP01ES012496 · NIEHS · DUKE UNIVERSITY · PI SCHWARTZ, DAVID A · 2003 to 2003
$1.5M
S-nitrosothiol-regulated pathways in acute lung injuryR21HL106121 · NHLBI · DUKE UNIVERSITY · PI FOSTER, MATTHEW WOLF, MARSHALL, HARVEY E · 2011 to 2012
$391k
NCRR NIH HHS UL1 RR024128NHLBI NIH HHS HL106121NHLBI NIH HHS R01 HL107590NHLBI NIH HHS R21 HL106121NIEHS NIH HHS ES012496NIEHS NIH HHS P01 ES012496NIEHS NIH HHS U19 ES012496
6 · The paper itself

Abstract

The analysis of airway fluid, as sampled by bronchoalveolar lavage (BAL), provides a minimally invasive route to interrogate lung biology in health and disease. Here, we used immunodepletion, coupled with gel- and label-free LC-MS/MS, for quantitation of the BAL fluid (BALF) proteome in samples recovered from human subjects following bronchoscopic instillation of saline, lipopolysaccharide (LPS) or house dust mite antigen into three distinct lung subsegments. Among more than 200 unique proteins quantified across nine samples, neutrophil granule-derived and acute phase proteins were most highly enriched in the LPS-exposed lobes. Of these, peptidoglycan response protein 1 was validated and confirmed as a novel marker of neutrophilic inflammation. Compared to a prior transcriptomic analysis of airway cells in this same cohort, the BALF proteome revealed a novel set of response factors. Independent of exposure, the enrichment of tracheal-expressed proteins in right lower lung lobes suggests a potential for constitutive intralobar variability in the BALF proteome; sampling of multiple lung subsegments also appears to aid in the identification of protein signatures that differentiate individuals at baseline. Collectively, this proof-of-concept study validates a robust workflow for BALF proteomics and demonstrates the complementary nature of proteomic and genomic techniques for investigating airway (patho)physiology.

Indexed as

AnimalsAntigensBlood ProteinsBronchoalveolar Lavage FluidCluster AnalysisHumansLipopolysaccharidesLungProteomeProteomicsPyroglyphidaeTandem Mass SpectrometryAntigensBlood ProteinsLipopolysaccharidesProteome

Identifiers

PMID23550723
PMCPMC3822014
OpenAlexW2095154137

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.